MTEX PHARMA UK LTD
Significant control: Mai Reda Ibrahim Eldosoky Youssef (75–100%), Mahmoud Mohamed Abdelkhalek Ramadan Eltantawi (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Mtex Pharma UK Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Mtex Pharma UK Ltd sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
MTEX PHARMA UK LTD is an active private limited company (company number 12533940) incorporated on 25 March 2020, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £164k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 36% on the prior period (£121k).
By net assets it sits in the top quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
Ownership and control
- Dr Mai Reda Ibrahim Eldosoky Youssef
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dr. Mahmoud Mohamed Abdelkhalek Ramadan Eltantawi
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 25 March 20206 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 8 April 2027in 166 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 73200
- Market research and public opinion polling
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £164k | — | — | £3,105 | — | — | 2 |
| 31 March 2024 | £121k | — | — | £2,518 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £164,365 at 31 March 2025
- Net assets up 10% or more on the prior period+36.4% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 15.48
- Incorporated five or more years agoIncorporated 25 March 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 166 days
- Next accounts duein 68 days
- Accounts period endNet assets £164k · micro accounts
- Accounts period endNet assets £121k · micro accounts
- Incorporated
Similar companies in London
Reminders for MTEX PHARMA UK LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.